"Concepts and Breakthroughs in Glaucoma" Conference
"Concepts and Breakthroughs in Glaucoma" Conference
批准号:
10317233
负责人:
W Daniel Stamer
金额:
$2.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2022-08-31
关键词:
AcademiaAdvanced DevelopmentAreaAwardBackBasic ScienceBlindnessCellular biologyClinicalClinical ResearchCollaborationsCountryDevelopmentDiagnosisDiseaseDisease ProgressionEnvironmentEyeFeedbackFellowshipFosteringFoundationsFunctional disorderFundingFutureGlaucomaGoalsHomeostasisIndividualIndustryInstitutionInternationalLearningLocationMentorshipMindMolecularMonitorMorehouse School of MedicineNatural regenerationOphthalmologistOptic DiskParticipantPathogenesisPathologyPatient CarePatientsPhysiologic Intraocular PressurePublic HealthRecording of previous eventsResearchResearch PersonnelReservationsResourcesRetinal Ganglion CellsScientistSecureSenior ScientistSeriesSocietiesStructureStudentsTissuesTranslatingTranslational ResearchTranslationsTravelUnderrepresented PopulationsUniversitiesVisionWomanWorkcareercareer developmentcell injuryeducational atmosphereethnic diversityimaging modalityinterestlecturesmeetingsmemberneuroprotectionnew technologynovelnovel therapeuticspostersrecruitrole modelsymposiumtranslational impact
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
This proposal seeks support for students and junior investigators (travel awardees) to attend the 2021 Inter-
national Society for Eye Research (ISER)-BrightFocus Foundation (BFF) glaucoma meeting titled "Concepts
and Breakthroughs in Glaucoma" to be held October 6th-9th, 2021 in Atlanta, Georgia at the Emory Conference
Center and Hotel. As was the case for the 2017 and 2019 meetings, our goal is to bring together basic
scientists, clinician-scientists, students and fellows for presentations and in-depth discussions on recent excit-
ing research advances and developments in molecular mechanisms underlying glaucomatous pathology, in
both the conventional outflow tract and the optic nerve head. Additionally, novel technologies developed: (i) to
diagnose and monitor disease progression, (ii) to modify/restore glaucomatous dysfunction, and (iii) to regen-
erate damaged cells/tissues will be presented. We have already recruited 5 thought leaders in glaucoma to
give keynote lectures at the conference. As with the 2017 and 2019 meetings, the platform sessions will be
selected exclusively from submitted abstracts. We have reserved one platform session for travel awardees
and we are again putting on a one-day "crash course" in glaucoma for people new to glaucoma and stu-
dents/junior investigators, consistent with our goal of increasing participation of young scientists. ISER and
BFF have an established history of promoting diversity, and the selected speakers (from abstracts) will repre-
sent a diverse group of scientists that includes women and members of historically underrepresented groups.
The Specific Aims of the conference are to:
1. Enhance the emerging careers of at least 30 young investigators working in glaucoma research, including
women and members of underrepresented groups, by providing travel awards.
2. Provide a forum for the dissemination of the most recent advances in glaucoma research.
3. Create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists,
and which will generate the opportunity for vision scientists with diverse personal and scientific back-
grounds to meet and establish research collaborations.
4. Bring together scientists working in disparate areas of glaucoma research.
We anticipate that this meeting will provide state-of-the-art information on recent advances in glaucoma and
will serve as an important resource for those involved in the translation of these findings into novel therapeu-
tics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop
potential collaborations among the attendees. The requested funds will support the travel, accommodation
and registration of 18 students (pre- and postdoctoral) and 12 junior investigators who otherwise would not
have the resources to attend this focused meeting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Basic Science Catalyzing Treatments for Glaucoma
-
批准号:9391815
-
项目类别:
-
资助金额:$2.41万
-
财政年份:2017
-
负责人:W Daniel Stamer
-
依托单位:
Ocular Pharmacology and Therapeutics Conference
-
批准号:8837851
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2014
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7015408
-
项目类别:
-
资助金额:$36.19万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7583931
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7350116
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7175368
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7761661
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
SELENIUM-INDUCED GLAUCOMA
-
批准号:6830135
-
项目类别:
-
资助金额:$15.05万
-
财政年份:2003
-
负责人:W Daniel Stamer
-
依托单位:
SELENIUM-INDUCED GLAUCOMA
-
批准号:6986093
-
项目类别:
-
资助金额:$14.7万
-
财政年份:2003
-
负责人:W Daniel Stamer
-
依托单位:
SELENIUM-INDUCED GLAUCOMA
-
批准号:6703848
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2003
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN REGULATION OF AQUEOUS HUMOR OUTFLOW
-
批准号:6470139
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2002
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN REGULATION OF AQUEOUS HUMOR OUTFLOW
-
批准号:6738013
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2002
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN REGULATION OF AQUEOUS HUMOR OUTFLOW
-
批准号:6623768
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2002
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6371007
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6904439
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6769550
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6518651
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
MOLECULAR BASIS OF MYOCILIN FUNCTION IN THE HUMAN EYE
-
批准号:7373344
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6603728
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Structural basis of ion channel function in Aquaporin-1
-
批准号:7151200
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2000
-
负责人:W Daniel Stamer
-
依托单位:
海外基金